Mallinckrodt Plans New Research Facility

DECEMBER 01, 2004

Mallinckrodt's expansion and relocation of its pharmaceutical research and development laboratory operations are under way. The 65,000-sq-ft facility, located on Marshall Road in Webster Groves, St. Louis, Mo, is slated for completion in the spring of 2005. The renovation will allow for a significant increase in Mallinckrodt's pharmaceutical research capabilities in St. Louis. It also represents the health care company's commitment to ongoing development of innovative generic drug products for human use.

A large segment of the research scientists currently working at Mallinckrodt's St. Louis production plant will relocate to the new facility upon its completion. Furthermore, the company anticipates adding 20 to 25 researchers over the next year. When up and running, the facility will house about 100 individuals. The existing St. Louis research facilities will be redesigned to meet the expanding needs of the company's chemical business.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.